chr10-77637558-T-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 1P and 4B. PP2BP4_ModerateBP6_Moderate
The NM_001161352.2(KCNMA1):c.85A>T(p.Ile29Phe) variant causes a missense change. The variant allele was found at a frequency of 0.0000298 in 1,542,920 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000032 ( 1 hom. )
Consequence
KCNMA1
NM_001161352.2 missense
NM_001161352.2 missense
Scores
3
4
12
Clinical Significance
Conservation
PhyloP100: 4.79
Genes affected
KCNMA1 (HGNC:6284): (potassium calcium-activated channel subfamily M alpha 1) This gene encodes the alpha subunit of calcium-activated BK channel. The encoded protein is involved in several physiological processes including smooth muscle contraction, neurotransmitter release and neuronal excitability. Mutations in this gene are associated with a spectrum of neurological disorders including Paroxysmal Nonkinesigenic Dyskinesia 3, Idiopathic Generalized Epilepsy 16 and Liang-Wang syndrome. [provided by RefSeq, Aug 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), KCNMA1. . Gene score misZ 5.0622 (greater than the threshold 3.09). Trascript score misZ 6.5162 (greater than threshold 3.09). GenCC has associacion of gene with cerebellar atrophy, developmental delay, and seizures, generalized epilepsy-paroxysmal dyskinesia syndrome, Liang-Wang syndrome.
BP4
Computational evidence support a benign effect (MetaRNN=0.2519365).
BP6
Variant 10-77637558-T-A is Benign according to our data. Variant chr10-77637558-T-A is described in ClinVar as [Likely_benign]. Clinvar id is 2905605.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNMA1 | NM_001161352.2 | c.85A>T | p.Ile29Phe | missense_variant | 1/28 | ENST00000286628.14 | NP_001154824.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNMA1 | ENST00000286628.14 | c.85A>T | p.Ile29Phe | missense_variant | 1/28 | 1 | NM_001161352.2 | ENSP00000286628.8 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151828Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
2
AN:
151828
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000879 AC: 13AN: 147822Hom.: 1 AF XY: 0.0000885 AC XY: 7AN XY: 79124
GnomAD3 exomes
AF:
AC:
13
AN:
147822
Hom.:
AF XY:
AC XY:
7
AN XY:
79124
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000316 AC: 44AN: 1390974Hom.: 1 Cov.: 30 AF XY: 0.0000422 AC XY: 29AN XY: 686688
GnomAD4 exome
AF:
AC:
44
AN:
1390974
Hom.:
Cov.:
30
AF XY:
AC XY:
29
AN XY:
686688
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151946Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74272
GnomAD4 genome
AF:
AC:
2
AN:
151946
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74272
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ExAC
AF:
AC:
8
Asia WGS
AF:
AC:
2
AN:
3476
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Generalized epilepsy-paroxysmal dyskinesia syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 29, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;.;.;.;.;.;.;.;.;.;.;T;.;T;.;.;.;.;.;.;.;.;.;.;T;.;.;.;.;.;.;.;.;.;.;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;.;D;D;D;D;D;D;D;D;D;D;D;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;N;N;N;.;N;.;.;N;N;N;.;.;N;.;.
PrimateAI
Pathogenic
D
PROVEAN
Benign
.;.;.;.;.;N;.;.;.;.;.;.;.;N;.;.;.;.;.;.;.;.;.;N;.;.;.;.;.;.;.;.;.;.;.;.;.
REVEL
Uncertain
Sift
Pathogenic
.;.;.;.;.;D;.;.;.;.;.;.;.;D;.;.;.;.;.;.;.;.;.;D;.;.;.;.;.;.;.;.;.;.;.;.;.
Sift4G
Benign
.;.;.;.;.;T;.;.;.;.;.;T;.;T;.;.;.;.;.;.;.;.;.;T;T;.;.;.;.;T;.;.;.;.;T;T;T
Polyphen
0.072, 0.98, 0.12, 0.85, 0.26, 0.99
.;.;.;.;.;B;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;D;.;B;P;.;.;B;.;B;.;.;.;.;D;.;.
Vest4
0.61, 0.72, 0.65, 0.53, 0.69, 0.49, 0.72, 0.78, 0.76
MutPred
Loss of catalytic residue at L34 (P = 0.0558);Loss of catalytic residue at L34 (P = 0.0558);Loss of catalytic residue at L34 (P = 0.0558);Loss of catalytic residue at L34 (P = 0.0558);Loss of catalytic residue at L34 (P = 0.0558);Loss of catalytic residue at L34 (P = 0.0558);Loss of catalytic residue at L34 (P = 0.0558);Loss of catalytic residue at L34 (P = 0.0558);Loss of catalytic residue at L34 (P = 0.0558);Loss of catalytic residue at L34 (P = 0.0558);Loss of catalytic residue at L34 (P = 0.0558);Loss of catalytic residue at L34 (P = 0.0558);Loss of catalytic residue at L34 (P = 0.0558);Loss of catalytic residue at L34 (P = 0.0558);Loss of catalytic residue at L34 (P = 0.0558);Loss of catalytic residue at L34 (P = 0.0558);Loss of catalytic residue at L34 (P = 0.0558);Loss of catalytic residue at L34 (P = 0.0558);Loss of catalytic residue at L34 (P = 0.0558);Loss of catalytic residue at L34 (P = 0.0558);Loss of catalytic residue at L34 (P = 0.0558);Loss of catalytic residue at L34 (P = 0.0558);Loss of catalytic residue at L34 (P = 0.0558);Loss of catalytic residue at L34 (P = 0.0558);Loss of catalytic residue at L34 (P = 0.0558);Loss of catalytic residue at L34 (P = 0.0558);Loss of catalytic residue at L34 (P = 0.0558);Loss of catalytic residue at L34 (P = 0.0558);Loss of catalytic residue at L34 (P = 0.0558);Loss of catalytic residue at L34 (P = 0.0558);Loss of catalytic residue at L34 (P = 0.0558);Loss of catalytic residue at L34 (P = 0.0558);Loss of catalytic residue at L34 (P = 0.0558);Loss of catalytic residue at L34 (P = 0.0558);Loss of catalytic residue at L34 (P = 0.0558);Loss of catalytic residue at L34 (P = 0.0558);Loss of catalytic residue at L34 (P = 0.0558);
MVP
0.72
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at